For instance, Liu et al. [34] showed that supplementing probiotics reduced AST levels in patients with NAFLD (MD: −13.11; 95% CI: −17.37, −8.85) as well as ALT levels (MD: −13. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.